A method for estimating catechol estrogen metabolism from excretion of noncatechol estrogens
β Scribed by H. M. Lemon; J. W. Heidel; J. F. Rodriguez-Sierra
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 604 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The relationship of catechol estrogen metabolism to disease has seldom been investigated because of analytic difficulties. Estradiol (E2) and estrone (El) are oxidized simultaneously at either ring A or ring D, and the rate of catechol estrogen formation (rz) is reciprocally related to the rate of 16a-hydroxylation (r3). The rate of ovarian estrogen production (X,J can be summarized as to metabolic outcome: X,, = rlo + rz + r, + ru, where r,, is the loss of E l and E2 in urine, and ru is the fecal and urinary loss of unknown oxidative products. Assuming a constant ru between subjects: X,, -r,, = rz f r,. The value rl0 is only a very small fraction of X,, and does not affect the constancy of the XI, concentration between subjects during similar menstrual cycle phases. In the absence of xenobiotics, r2 and rn are reciprocally interrelated: rz x r3 = K (an oxidation constant whose limiting factor is the biologically available estrogen at the cell surface). To the extent that r,, approximates estrogens available for cellular metabolism, the rate of catechol estrogen metabolism may be determined from
From published data K = 12.4 f 0.8 of the standard error of the mean. Pearson correlation coefficients between actual and estimated catechol estrogen excretion in groups of subjects ranged from 0.61 to 0.97 (median, 0.88). This method has been useful for clinical investigation of the relationship of catechol estrogen metabolism to disease until better methods to measure catechol estrogen directly are available.
π SIMILAR VOLUMES
The comparison of routine pharmacokinetic data obtained after intravenous and oral drug administration allows to figure out that some quantity of drug, which reached the systemic circulation, was eliminated from the body by routes other than hepatic metabolism and renal excretion. This quantity is e
To establish a prediction system for drug-induced gynecomastia in clinical fields, a model reaction system was developed to explain numerically this side effect. The principle is based on the assumption that 50% inhibition concentration (IC 50 ) of drugs on the in vitro metabolism of estradiol (E2)